Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CORBF NASDAQ:KDLY NASDAQ:QIPT NASDAQ:SERA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCORBFGlobal Cord Blood$1.05$0.97$0.25▼$1.75$127.63M-0.692,256 shs113 shsKDLYKindly MD$8.08+77.2%$9.81$0.65▼$34.77$48.66MN/A2.29 million shs15.47 million shsQIPTQuipt Home Medical$2.63+1.4%$2.20$1.35▼$3.27$114.03M0.6570,481 shs251,723 shsSERASera Prognostics$3.09-0.3%$2.77$1.37▼$9.13$116.40M1215,679 shs82,297 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCORBFGlobal Cord Blood0.00%0.00%-22.22%-16.00%-30.00%KDLYKindly MD+11.76%-16.18%-52.35%-60.69%+245.45%QIPTQuipt Home Medical+0.39%0.00%+21.60%+22.17%-4.43%SERASera Prognostics-2.21%-6.91%+25.00%+106.67%-57.53%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCORBFGlobal Cord Blood$1.05$0.97$0.25▼$1.75$127.63M-0.692,256 shs113 shsKDLYKindly MD$8.08+77.2%$9.81$0.65▼$34.77$48.66MN/A2.29 million shs15.47 million shsQIPTQuipt Home Medical$2.63+1.4%$2.20$1.35▼$3.27$114.03M0.6570,481 shs251,723 shsSERASera Prognostics$3.09-0.3%$2.77$1.37▼$9.13$116.40M1215,679 shs82,297 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCORBFGlobal Cord Blood0.00%0.00%-22.22%-16.00%-30.00%KDLYKindly MD+11.76%-16.18%-52.35%-60.69%+245.45%QIPTQuipt Home Medical+0.39%0.00%+21.60%+22.17%-4.43%SERASera Prognostics-2.21%-6.91%+25.00%+106.67%-57.53%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCORBFGlobal Cord Blood 0.00N/AN/AN/AKDLYKindly MD 0.00N/AN/AN/AQIPTQuipt Home Medical 2.50Moderate Buy$3.1520.92% UpsideSERASera Prognostics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest KDLY, CORBF, SERA, and QIPT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/19/2025QIPTQuipt Home MedicalCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$1.70 ➝ $2.30(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCORBFGlobal Cord Blood$196.12M0.65$0.75 per share1.40N/A∞KDLYKindly MD$2.47M19.70N/AN/AN/A∞QIPTQuipt Home Medical$245.91M0.46$1.03 per share2.54$2.49 per share1.05SERASera Prognostics$80K1,527.99N/AN/A$1.40 per share2.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCORBFGlobal Cord Blood$79.04MN/A0.00∞N/AN/AN/AN/AN/AKDLYKindly MDN/A-$0.77N/A∞N/AN/AN/AN/AN/AQIPTQuipt Home Medical-$6.76M-$0.24N/AN/AN/A-4.30%-9.78%-4.23%N/ASERASera Prognostics-$32.90M-$0.85N/AN/AN/A-30,306.48%-45.86%-34.31%11/5/2025 (Estimated)Latest KDLY, CORBF, SERA, and QIPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q3 2025QIPTQuipt Home Medical$0.03-$0.07-$0.10-$0.07$80.37 million$58.30 million8/6/2025Q2 2025SERASera Prognostics-$0.21-$0.16+$0.05-$0.16$0.05 million$0.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCORBFGlobal Cord BloodN/AN/AN/AN/AN/AKDLYKindly MDN/AN/AN/AN/AN/AQIPTQuipt Home MedicalN/AN/AN/AN/AN/ASERASera PrognosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCORBFGlobal Cord BloodN/AN/AN/AKDLYKindly MDN/A5.435.42QIPTQuipt Home Medical0.711.150.75SERASera PrognosticsN/A1.731.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCORBFGlobal Cord BloodN/AKDLYKindly MDN/AQIPTQuipt Home Medical42.85%SERASera Prognostics54.64%Insider OwnershipCompanyInsider OwnershipCORBFGlobal Cord Blood0.50%KDLYKindly MD50.50%QIPTQuipt Home Medical13.40%SERASera Prognostics15.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCORBFGlobal Cord Blood1,200121.55 millionN/ANot OptionableKDLYKindly MDN/A6.02 million2.96 millionN/AQIPTQuipt Home Medical1,20043.44 million37.62 millionOptionableSERASera Prognostics12037.67 million31.72 millionOptionableKDLY, CORBF, SERA, and QIPT HeadlinesRecent News About These CompaniesSera Prognostics (NASDAQ:SERA) Director Sandra Aj Lawrence Sells 3,899 SharesSeptember 10 at 7:51 AM | insidertrades.comSera Prognostics, Inc. (NASDAQ:SERA) Short Interest UpdateSeptember 9 at 11:40 AM | marketbeat.comSera Prognostics Highlights Strategy at Investment ConferenceSeptember 6, 2025 | msn.comSera Prognostics, Inc. $SERA Shares Purchased by AWM Investment Company Inc.September 5, 2025 | marketbeat.comGhisallo Capital Management LLC Makes New $368,000 Investment in Sera Prognostics, Inc. $SERASeptember 2, 2025 | marketbeat.comSERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCEAugust 28, 2025 | prnewswire.comAberdeen Group plc Invests $4.56 Million in Sera Prognostics, Inc. $SERAAugust 23, 2025 | marketbeat.comRobert Gardner Harrison Sells 6,000 Shares of Sera Prognostics (NASDAQ:SERA) StockAugust 21, 2025 | insidertrades.comSera Prognostics (NASDAQ:SERA) Lowered to Sell Rating by Wall Street ZenAugust 10, 2025 | marketbeat.comSera Prognostics, Inc. (NASDAQ:SERA) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | msn.comSera Prognostics outlines European expansion and new commercial hires while targeting PreTRM Test reimbursement pilotsAugust 7, 2025 | msn.comSera Prognostics, Inc. (SERA) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comSera Prognostics (SERA) Q2 Loss Down 4%August 6, 2025 | fool.comSera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue EstimatesAugust 6, 2025 | zacks.comSERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTSAugust 6, 2025 | prnewswire.comSera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025July 29, 2025 | prnewswire.comSera Prognostics director Mirza sells $552 in stockJuly 10, 2025 | investing.comSera Prognostics (NASDAQ:SERA) Stock, Insider Trading ActivityJune 30, 2025 | benzinga.comSera Prognostics: PreTRM Labor Test Should Represent Advance In Risk AssessmentJune 30, 2025 | seekingalpha.comSera Prognostics, Inc. (NASDAQ:SERA) CEO Sells $32,950.06 in StockJune 12, 2025 | insidertrades.comWe Think Sera Prognostics (NASDAQ:SERA) Needs To Drive Business Growth CarefullyJune 10, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKDLY, CORBF, SERA, and QIPT Company DescriptionsGlobal Cord Blood NYSE:CORBF$1.05 0.00 (0.00%) As of 09/9/2025Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.Kindly MD NASDAQ:KDLY$8.08 +3.52 (+77.19%) As of 09/9/2025Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.Quipt Home Medical NASDAQ:QIPT$2.62 +0.04 (+1.35%) Closing price 03:59 PM EasternExtended Trading$2.63 +0.00 (+0.19%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.Sera Prognostics NASDAQ:SERA$3.09 -0.01 (-0.32%) Closing price 03:58 PM EasternExtended Trading$3.10 +0.01 (+0.32%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Celsius Stock Surges After Blowout Earnings and Pepsi Deal Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Alphabet Stock’s Weakness Was Wall Street’s Opportunity Should You Buy Figma Stock After Its 55% Post-IPO Drop? Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead Forget QQQ: This ETF Marries the Magnificent 7 and Communications Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
